SRL
TXG icon

Scientech Research LLC’s 10x Genomics TXG Stock Holding History

Scientech Research LLC’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,213
Closed -$167K – 737
2025
Q4 		$167K Sell
10,213
-40,031
-80% -$605K 0.1% 366
2025
Q3 		$587K Buy
50,244
+17,212
+52% +$224K 0.2% 215
2025
Q2 		$383K Buy
+33,032
New +$301K 0.09% 394
2025
Q1 		– Sell
-11,136
Closed -$160K – 825
2024
Q4 		$160K Sell
11,136
-17,823
-62% -$281K 0.05% 502
2024
Q3 		$654K Buy
+28,959
New +$599K 0.13% 306

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Scientech Research LLC's TXG Position: Q1 2026 in Review

Scientech Research LLC sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 10,213 shares — an estimated $167K sold.

Scientech Research LLC first reported a position in TXG in Q3 2024 and held it in 5 quarters. The position peaked at $654K in Q3 2024. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Scientech Research LLC reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Scientech Research LLC sold 10,213 10x Genomics shares in Q1 2026, an estimated $167K.
  • Scientech Research LLC first reported a position in 10x Genomics in Q3 2024 and held it in 5 quarters.
  • Scientech Research LLC's 10x Genomics position peaked at $654K in Q3 2024.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.